Everest Medicines has announced groundbreaking results from its Phase 1b/2a clinical trial of EVER001, a novel Bruton’s tyrosine kinase...
Read MoreBranston, one of the UK’s leading potato suppliers, is gearing up to launch an exciting new brand, Nanna Tate,...
Read MoreTeva Pharmaceutical Industries has unveiled encouraging results from its Phase 3 SPACE study, highlighting the efficacy and safety of...
Read MoreVirtue Drinks, a pioneering clean-label beverage company, has successfully closed a £2m funding round as it gears up to...
Read MoreA groundbreaking new treatment for asthma and chronic obstructive pulmonary disease (COPD) could revolutionise how these life-threatening conditions are...
Read MoreIn a significant milestone for autoimmune disease research, argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative...
Read More